Photo via Semafor

Africa CDC director calls for local vaccine manufacturing

Read the original at Semafor ↗
Cite

Lim, D. (2026, September 22). Africa CDC director calls for local vaccine manufacturing. Semafor. https://www.semafor.com/article/09/22/2026/africa-cdc-director-calls-for-local-vaccine-manufacturing

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Semafor · collected 2026-09-22 · by David Lim

Quick Summary

Jean Kaseya, Director-General of the Africa Centres for Disease Control, emphasized during Semafor’s The Next 3 billion event that Africa needs to start manufacturing its own vaccines due to the ongoing impact of the Bundibugyo Ebola outbreak in Uganda, the Democratic Republic of Congo, Rwanda, and Burundi. According to the World Health Organization, there have been 6,778 cases and 3269 deaths in this current outbreak. Kaseya highlighted that despite knowing about the Bundibugyo virus strain for 19 years, no specific vaccine has yet been developed, criticizing foreign companies' approaches of manufacturing vaccines abroad at no cost.
Written by AI on 2026-09-22, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Jean Kaseya, Director-General of the Africa Centres for Disease Control, called on African countries to start manufacturing vaccines locally during a recent event in Uganda. The urgent call came amid the ongoing Bundibugyo Ebola outbreak, which has affected economies in Uganda, the Democratic Republic of the Congo (DRC), Rwanda, and Burundi. Since the outbreak began, there have been 6,778 confirmed cases and 3,269 deaths according to the World Health Organization (WHO). Although WHO announced an end to Uganda’s outbreak in late August, transmission is still active in the DRC. Kaseya noted that despite discovering the Bundibugyo virus strain nearly two decades ago, no specific vaccine has been developed yet. He pointed out that if such a discovery had occurred elsewhere, like the U.S. or Europe, a vaccine might already exist by now. A vaccine for the Zaire Ebola strain is currently in Phase 3 trials to determine its efficacy against Bundibugyo and results are expected later this year.

Written for “African Vaccine Manufacturing Call” on 2026-11-02, grounded in this article and the 0 other(s) covering the same event.

Story

📰 African Vaccine Manufacturing Call
Health · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 20% of its claims. Each row says how that neighbour differs.
Congo Ebola contact tracing falls far short as outbreak spreads, Africa CDC chief says Different event
The Straits Times
Hedges 3 of 17 claims Outlet record 66/100
“The articles describe different aspects of the Ebola response; one focuses on local vaccine manufacturing while the other discusses shortcomings in contact tracing.”
Ebola spreads in DR Congo, putting neighbouring nations at risk Different event
Al Jazeera
Hedges 0 of 1 claims Outlet record 60/100
“The articles describe different stages of the Ebola outbreak, with Article A focusing on a call for local vaccine manufacturing due to an ongoing outbreak and Article B reporting on the spread of the disease to new areas in DR Congo.”
'When fear takes over': Responding to the DRC's largest Ebola outbreak Different event
ABC News (AU)
Hedges 5 of 55 claims Outlet record 68/100
“The articles cover different aspects of the Ebola outbreak response in Africa; one focuses on a call for local vaccine manufacturing while the other details the experiences and challenges faced by healthcare workers in the Democratic Republic of Congo.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
10
sentences that state something as happening or true
Uncertain
20%
2 of 10 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
59/100
Semafor's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-22 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Semafor · 1423 article(s) · 3 correction(s) detected
Running correction rate · 3 correction(s)
2026-11-02
Tech earnings prompt ‘sober questions’
2026-11-02
AI trade falters after disappointing tech earnings
2026-10-16
LA's 'Selling Sunset' real estate agency opens a Dubai office

Who wrote this

David Lim
13 article(s) here · 1 carrying a prediction
🔮 The slowdown could happen in a number of ways, GOP aides working on health policy told me — depending on how big an election night Democrats have.
2026-10-29 · mixed framing · Republicans prep for slowdown of Trump’s healthcare agenda
🔮 But the food industry has raised concerns over what impact the forthcoming proposed definition could have on lawsuits across the country, and the White House is still scheduled to meet separately with several groups to discuss the issue in the coming weeks — including the National Restaurant Association on Tuesday, the Center for Food Safety on Thursday, and the Consumer Brands Association and Flavor and Extract Manufacturers Association in the days after the midterms.
2026-10-26 · mixed framing · Trump administration weighs ultra-processed food definition
🔮 Now the question is whether Kennedy could reconsolidate the same voters if he launches a new bid for the presidency.
2026-10-22 · assertive framing · The fight for MAHA's soul
🔮 A pending regulation under White House review could expand access to peptides, largely unregulated substances that are popular with wellness influencers and Health and Human Services Secretary Robert F. Kennedy Jr. In July, a panel of outside advisers to the Food and Drug Administration — which included individuals with connections to the peptide industry — narrowly recommended adding several peptides to the agency’s list of products that can be compounded, or mixed at pharmacies, despite concerns from FDA scientists.
2026-10-19 · speculative framing · Peptide group to meet with White House over pending regulatory plan
🔮 If Republicans ultimately support her, Overton will lead the agency responsible for vaccine policy after making a bigger contribution to the Trump administration’s effort to reverse decades of American policy on childhood vaccines than was widely understood.
2026-10-15 · assertive framing · Trump FDA nominee played key role in overhaul of childhood vaccine policy
🔮 With Sens. Roger Marshall, R-Kansas, and Susan Collins, R-Maine, fighting difficult reelection battles, it’s unclear who will replace Louisiana Sen. Bill Cassidy as the top Republican on the Senate HELP Committee.
2026-10-08 · mixed framing · Republican leadership of Senate health panel in doubt
🔮 When asked about his vote, Whitehouse pointed to a longstanding Rhode Island Medicare reimbursement policy issue he said he hopes Klomp will help resolve.
2026-09-25 · assertive framing · Klomp wins over Democrat in bid to be No. 2 HHS official
🔮 The Trump administration is backing off its initial plan for an executive order that would give the president greater influence over decisionmaking on National Institutes of Health grants, according to three people familiar with the process.
2026-09-23 · mixed framing · Trump administration backing off NIH grant order amid pushback
🔮 “You can imagine if here in the U.S., in Europe, we knew this Bundibugyo for 19 years, the vaccine would already be available,” Kaseya said.
2026-09-22 · assertive framing · Africa CDC director calls for local vaccine manufacturing
🔮 President Trump took a victory lap on his administration’s work on drug pricing today, announcing all 50 states will participate in the “most-favored-nation” program, saying “this one thing alone should win us the midterms.”
2026-09-18 · assertive framing · Health wonks question who saves in Trump drug program
Also by David Lim
Republicans prep for slowdown of Trump’s healthcare agenda
2026-10-29 · Semafor
Trump administration weighs ultra-processed food definition
2026-10-26 · Semafor
The fight for MAHA's soul
2026-10-22 · Semafor
Peptide group to meet with White House over pending regulatory plan
2026-10-19 · Semafor
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 13 articles by David Lim →

Topics

Bundibugyo Rwanda Uganda the Africa Centres for Disease Control the Democratic Republic of the Congo

Subjects

Bundibugyo GPE · 5× Kaseya PERSON · 3× Uganda GPE · 2× Burundi GPE · 1× Jean Kaseya PERSON · 1× Rwanda GPE · 1× Semafor ORG · 1× the Africa Centres for Disease Control ORG · 1× the Democratic Republic of the Congo GPE · 1× the World Health Organization ORG · 1×

Narrative

Director-General of the Africa Centres for Disease Control Jean Kaseya said Tuesday that the continent should begin making vaccines locally, as the Bundibugyo Ebola outbreak continues to have a huge impact on the economies of Uganda, the Democratic Republic of the Congo, Rwanda and Burundi.
framing: assertive · carried by 1 article(s) · first seen 2026-09-22
🔮 “You can imagine if here in the U.S., in Europe, we knew this Bundibugyo for 19 years, the vaccine would already be available,” Kaseya said.
2026-09-22 · Semafor
Africa CDC director calls for local vaccine manufacturing · assertive framing

Claims (10 extracted, 2 hedged)

Director-General of the Africa Centres for Disease Control Jean Kaseya said Tuesday that the continent should begin making vaccines locally, as the Bundibugyo Ebola outbreak continues to have a huge impact on the economies of Uganda, the Democratic Republic of the Congo, Rwanda and Burundi. asserted
outbreak → say → Congo
“It’s time for us to manufacture our own vaccines,” Kaseya said at Semafor’s The Next 3 Billion. asserted
Kaseya → ’ → Semafor
To date, 6,778 cases of Ebola and 3269 deaths have been documented in the current outbreak, according to the World Health Organization. uncertain
cases → document → Organization
The WHO announced an end to Uganda’s outbreak in late August, transmission is still ongoing in the DRC. asserted
transmission → announce → DRC
Kaseya said that even though it has been 19 years since the Bundibugyo virus strain was discovered, there is not yet a vaccine available. asserted
strain → say → ?
“You can imagine if here in the U.S., in Europe, we knew this Bundibugyo for 19 years, the vaccine would already be available,” Kaseya said. asserted
Kaseya → imagine → years
A vaccine developed for the Zaire Ebola strain is currently in a Phase 3 trial to see if it can be used for Bundibugyo – and results are expected by the end of this year. asserted
results → develop → year
There are clinical trials for multiple other vaccine candidates being pursued, but “it will take some time” to know if any are good matches for Bundibugyo, he added. asserted
he → be → Bundibugyo
The public health official estimated it may take about six months to determine if one is a specific vaccine for Bundibugyo. uncertain
one → estimate → Bundibugyo
He also said that it is not adequate for companies to say that they will manufacture vaccines abroad at no cost and bring them to Africa. asserted
they → say → Africa
💬Give feedback
🕘History 🎫Support
Terms · Privacy · beta v2.0.0
Articles to 2 Nov 2026